Ocasa Executive and Leadership Team

Santiago Castro Piccolo, the Chief Executive Officer at Ocasa, directs the overarching strategic vision for the organization. By prioritizing high-compliance logistics for the life sciences sector, the Chief Executive Officer ensures that all cold chain management protocols meet stringent international regulatory standards. This leadership role involves constant coordination with the Board to expand market presence across Latin America while maintaining operational excellence in pharmaceutical distribution. Santiago Castro Piccolo drives the integration of advanced tracking technologies to safeguard temperature-sensitive medical devices and biotechnology products throughout the entire supply chain. Through the implementation of robust quality control frameworks, the Chief Executive Officer secures the company's reputation as a reliable partner for healthcare providers. Ultimately, the Chief Executive Officer fosters a culture of precision and safety, ensuring that every shipment maintains absolute integrity from origin to final destination within the complex healthcare landscape.

Maria Ramperti, the Chief Financial Officer at Ocasa, manages the fiscal health and capital allocation strategies necessary for sustaining complex logistics operations. Overseeing financial planning and analysis, the Chief Financial Officer ensures that investments in cold chain infrastructure align with long-term growth objectives in the life sciences sector. This role requires meticulous monitoring of regulatory compliance costs and operational expenditures across diverse regional markets. Maria Ramperti drives the development of financial models that support the expansion of pharmaceutical distribution networks throughout Latin America. By optimizing resource distribution, the Chief Financial Officer strengthens the company's ability to handle sensitive medical materials with high efficiency. Through rigorous oversight of budgetary performance, Ramperti provides the necessary stability for the organization to navigate the volatile healthcare logistics environment. Ultimately, the Chief Financial Officer secures the financial foundation required to maintain the high-quality standards demanded by biotechnology clients.

Rolando del Rio, the President at Ocasa, directs the operational execution of specialized supply chain services for the life sciences industry. Focusing on the technical requirements of temperature-sensitive pharmaceutical distribution, the President ensures that all logistics processes adhere to strict regulatory mandates. This leadership role involves managing cross-functional teams to optimize the handling of medical devices and biotechnology products across regional borders. Rolando del Rio drives the implementation of standardized cold chain protocols to prevent product degradation during transit. By coordinating with internal quality assurance departments, the President maintains the integrity of healthcare materials throughout the entire distribution cycle. Through the continuous refinement of operational workflows, del Rio enhances the company's capacity to serve complex healthcare sectors. Ultimately, the President secures operational reliability, ensuring that every logistical solution meets the precise needs of pharmaceutical partners operating within the Latin American market.

Hernan Avruj, the President at Ocasa, oversees the expansion of market reach and the development of strategic partnerships within the healthcare logistics sector. Concentrating on the commercial growth of life sciences solutions, the President identifies new opportunities to provide specialized distribution services for biotechnology firms. This leadership role involves aligning service offerings with the evolving regulatory requirements of the pharmaceutical industry. Hernan Avruj drives the integration of client-focused logistics strategies that prioritize the safe transport of temperature-sensitive materials. By fostering relationships with key stakeholders, the President ensures that the company remains a preferred partner for medical device manufacturers across Latin America. Through the analysis of market trends, Avruj shapes the commercial direction of the organization to maintain a competitive edge. Ultimately, the President secures long-term business development, ensuring that the company's logistics capabilities consistently address the critical needs of the global healthcare community.

J. Spolski, the President at Ocasa, manages the technological infrastructure and digital transformation initiatives essential for modernizing life sciences logistics. Focusing on the implementation of advanced monitoring systems, the President ensures that real-time data visibility is maintained for all temperature-sensitive pharmaceutical shipments. This leadership role involves overseeing the deployment of secure, compliant digital platforms that track medical devices and biotechnology products throughout the supply chain. J. Spolski drives the adoption of innovative logistics software to enhance operational transparency and regulatory reporting capabilities. By streamlining digital workflows, the President improves the efficiency of cold chain management across diverse regional operations. Through the continuous assessment of technological needs, Spolski ensures that the company remains at the forefront of digital logistics solutions for the healthcare sector. Ultimately, the President secures the technological backbone of the organization, enabling precise and reliable distribution services for all life sciences clients.